Publications

  1. Rodrigues Pessoa R, Nabavizadeh R, Shah P, Frank I, Tollefson M, Sharma V, Rangel LJ, Cheville JC, Karnes RJ, Boorjian SA. Relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy. Prostate Cancer Prostatic Dis. 2024 Dec; 27 (4):674-679 Epub 2023 Sept 15
    View PubMed
  2. Deol ES, Nabavizadeh R, Lavoie RR, Dumbrava MG, Horjeti E, Thapa P, Cheville JC, Frank I, Lucien F. Role of B7-H3 in predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. BJUI Compass. 2024 Nov; 5 (11):1052-1058 Epub 2024 Sept 11
    View PubMed
  3. Sharma V, Fadel A, Tollefson MK, Psutka SP, Blezek DJ, Frank I, Thapa P, Tarrell R, Viers LD, Potretzke AM, Hartman RP, Boorjian SA, Viers BR. Artificial Intelligence-Based Assessment of Preoperative Body Composition is Associated With Early Complications After Radical Cystectomy. J Urol. 2024 Oct 11; 101097JU0000000000004292 [Epub ahead of print]
    View PubMed
  4. Deol ES, Sharma V, Fadel AE, Vasdev R, Henning G, Basourakos S, Ghaffar U, Tollefson MK, Frank I, Houston Thompson R, Karnes RJ, Boorjian SA, Khanna A. Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose? Urology. 2024 Aug 28 [Epub ahead of print]
    View PubMed
  5. Campbell RA, Khanna A, Boorjian SA, Knorr J, Cox R, Nicholas M, Cheville J, Sharma V, Murthy PB, Tarrell R, Thapa P, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Haber GP, Lee B. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy. Clin Genitourin Cancer. 2024 Apr; 22 (2):157-163.e1 Epub 2023 Oct 26
    View PubMed
  6. Khanna A, Antolin A, Bar O, Ben-Ayoun D, Zohar M, Boorjian SA, Frank I, Shah P, Sharma V, Thompson RH, Wolf T, Asselmann D, Tollefson M. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence. J Urol. 2024 Apr; 211 (4):575-584 Epub 2024 Jan 24
    View PubMed
  7. Mian AH, Tollefson MK, Shah P, Sharma V, Mian A, Thompson RH, Boorjian SA, Frank I, Khanna A. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy. J Clin Med. 2024 Jan 9; 13 (2) Epub 2024 Jan 09
    View PubMed
  8. Nabavizadeh R, Rodrigues Pessoa R, Dumbrava MG, Packiam VT, Thapa P, Tarrell R, Tollefson MK, Jeffrey Karnes R, Frank I, Khanna A, Shah P, Sharma V, Boorjian SA. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series. Urology. 2023 Nov; 181:162-166 Epub 2023 Sept 07
    View PubMed
  9. Zganjar A, Toussi A, Ziegelmann M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial. BJU Int. 2023 Aug; 132 (2):217-226 Epub 2023 May 09
    View PubMed
  10. Britton CJ, Sharma V, Fadel AE, Bearrick E, Findlay BL, Frank I, Tollefson MK, Karnes RJ, Viers BR. Vesicourethral Anastomotic Stenosis Following Radical Prostatectomy: Risk Factors, Natural History, and Treatment Outcomes. J Urol. 2023 Aug; 210 (2):312-322 Epub 2023 Apr 20
    View PubMed
  11. Myers A, Frank I, Shah PH, Tarrell RF, Baird B, Dora C, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA, Lyon TD. Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy. J Urol. 2023 Mar; 209 (3):525-531 Epub 2022 Nov 29
    View PubMed
  12. Avulova S, Benidir T, Cheville JC, Packiam VT, Shah P, Frank I, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Kulkarni G, Boorjian SA. Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy. Arch Pathol Lab Med. 2023 Feb 1; 147 (2):202-207
    View PubMed
  13. Britton CJ, Gottlich HC, Tarrell RF, Thapa P, Joyce DD, Shah PH, Sharma V, Boorjian SA, Frank I, Potretzke AM. Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy. Urology. 2023 Feb; 172:149-156 Epub 2022 Nov 25
    View PubMed
  14. Joyce DD, Soligo M, Morlacco A, Latuche LJR, Schulte PJ, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy. Eur Urol Open Sci. 2023 Jan; 47:87-93 Epub 2022 Dec 15
    View PubMed
  15. Tsivian M, Bole R, Packiam VT, Boorjian SA, Thapa P, Frank I, Tollefson MK. The Association of Trainee Involvement in Radical Cystectomy With Perioperative and Oncologic Outcomes. Urology. 2022 Jul; 165:128-133 Epub 2022 Jan 15
    View PubMed
  16. Mahmoud AM, Frank I, Orme JJ, Lavoie RR, Thapa P, Costello BA, Cheville JC, Gupta S, Dong H, Lucien F. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer. BMC Urol. 2022 Jun 24; 22 (1):90 Epub 2022 June 24
    View PubMed
  17. Anderson AL, Tollefson MK, Frank I, Peffley ND, Schroeder DR, Gali B. Intraoperative Ventilatory Pressures During Robotic Assisted vs Open Radical Cystectomy. Urology. 2022 Jun; 164:157-162 Epub 2021 Dec 10
    View PubMed
  18. Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SA. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558. Epub 2021 Oct 25.
    View PubMed
  19. Miest T, Khanna A, Sharma V, Hensley PJ, Campbell R, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Potretzke A, Matin SF, Murthy PB, Haber GP, Lee B, Boorjian SA. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy. J Urol. 2022 Feb; 207(2):284-292. Epub 2021 Sep 22.
    View PubMed
  20. Gordetsky JB, Montgomery KW, Giannico GA, Rais-Bahrami S, Thapa P, Boorjian S, Frank I, Cheville J. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer. Int J Surg Pathol. 2022 Feb; 30 (1):6-14 Epub 2021 June 28
    View PubMed
  21. Khanna A, Zganjar A, Lyon T, Shah P, Tollefson MK, Karnes RJ, Tarrell R, Thapa P, Thompson RH, Frank I, Boorjian SA. A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy. J Urol. 2021 Oct; 206 (4):970-977 Epub 2021 May 25
    View PubMed
  22. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206 (3):558-567 Epub 2021 Apr 28
    View PubMed
  23. Miest TS, Sharma V, Karnes RJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK. Incidence and predictors of occult preoperative deep vein thrombosis at radical cystectomy for urothelial carcinoma. Can Urol Assoc J. 2021 Sep; 15 (9):E471-E475
    View PubMed
  24. Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of a Novel Penile Traction Device in Improving Penile Length and Erectile Function Post Prostatectomy: Results from a Single-Center Randomized, Controlled Trial. J Urol. 2021 Aug; 206 (2):416-426 Epub 2021 June 01
    View PubMed
  25. Packiam VT, Labbate CV, Boorjian SA, Tarrell R, Cheville JC, Avulova S, Sharma V, Tsivian M, Adamic B, Mahmoud M, Werntz RP, Smith ND, Karnes RJ, Tollefson MK, Steinberg GD, Frank I. The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis. Urol Oncol. 2021 Jul; 39 (7):436.e1-436.e8 Epub 2021 Jan 21
    View PubMed
  26. Miest TS, Sharma V, Boeri L, Tollefson MK, Thompson RH, Boorjian SA, Frank I, Karnes RJ. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications? Urology. 2021 Jul; 153:215-220 Epub 2020 Aug 05
    View PubMed
  27. Lyon TD, Frank I, Tollefson MK, Tarrell RF, Shah PH, Thompson RH, Karnes RJ, Boorjian SA. Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy. Urol Oncol. 2021 Jun; 39 (6):370.e1-370.e8 Epub 2020 Dec 08
    View PubMed
  28. Takeuchi M, McDonald JS, Takahashi N, Frank I, Thompson RH, King BF, Kawashima A. Cancer Prevalence and Risk Stratification in Adults Presenting With Hematuria: A Population-Based Cohort Study. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):308-319 Epub 2021 Jan 21
    View PubMed
  29. Lyon TD, Henry MR, Shah PH, Boorjian SA, Tollefson MK, Frank I. Development of a technique for evaluating the presence of malignant cells in prostatic fluid during robotic prostatectomy. Urol Oncol. 2021 Mar; 39 (3):192.e1-192.e6 Epub 2020 Aug 29
    View PubMed
  30. Minkler S, Lucien F, Kimber MJ, Sahoo DK, Bourgois-Mochel A, Musser M, Johannes C, Frank I, Cheville J, Allenspach K, Mochel JP. Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man's Trash Is Another Man's Treasure. Cancers (Basel). 2021 Jan 23; 13 (3)
    View PubMed
  31. Packiam VT, Tsivian M, Avulova S, Sharma V, Tarrell R, Cheville JC, Frank I, Thompson RH, Tollefson MK, Gettman MT, Karnes RJ, Thapa P, Boorjian SA. Long-term outcomes of incidental prostate cancer at radical cystectomy. Urol Oncol. 2020 Nov; 38 (11):848.e17-848.e22 Epub 2020 July 02
    View PubMed
  32. Joseph JP, Glasgow AE, Carlson RE, Frank I, Tollefson MK, Boorjian SA, Thompson RH, Karnes RJ, Habermann EB, Gettman MT. Screening Postoperative Hemoglobin after Robot-Assisted Radical Prostatectomy-Frequently Used, but Is It Necessary? Urol Pract. 2020 Nov; 7(6):554-558. Epub 2019 Dec 02.
    View PubMed
  33. Gordetsky J, Spieker AJ, Pena MDCR, Kamanda S, Anderson MR, Cheville J, Boorjian S, Frank I, Granada CP, Comperat E, Hirsch MS, Iczkowski KA, Imblum B, Schwartz L, Giannico GA, Rais-Bahrami S. Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV. Urology. 2020 Oct; 144:158-163 Epub 2020 July 16
    View PubMed
  34. Andrews JR, Sobol I, Frank I, Gettman MT, Thompson RH, Karnes RJ, Boorjian SA, Tollefson MK. Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection. Urology. 2020 Sep; 143:181-185 Epub 2020 June 17
    View PubMed
  35. Agarwal DK, Sharma V, Toussi A, Viers BR, Tollefson MK, Gettman MT, Frank I. Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies. Eur Urol. 2020 Mar; 77 (3):373-379 Epub 2019 Apr 19
    View PubMed
  36. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. AUTHOR REPLY. Urology 2020 Feb; 136:111
    View PubMed
  37. Lyon TD, Shah ND, Tollefson MK, Shah PH, Sangaralingham LR, Asante D, Thompson RH, Karnes RJ, Frank I, Boorjian SA. Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy. Urology. 2020 Feb; 136:105-111 Epub 2019 Nov 09
    View PubMed
  38. Yang DY, Frank I, Avant RA, Miller AR, Thapa P, Boorjian SA, Tollefson MK. Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy. Urol Oncol. 2019 Dec; 37 (12):886-892 Epub 2019 Aug 17
    View PubMed
  39. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Tarrel R, Quevedo FJ, Cheville JC, Karnes RJ. Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience. World J Urol. 2019 Nov; 37 (11):2409-2418 Epub 2019 Feb 25
    View PubMed
  40. Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease. World J Urol. 2019 Aug; 37 (8):1605-1613 Epub 2018 Nov 03
    View PubMed
  41. Hebert KJ, Joseph J, Gettman M, Tollefson M, Frank I, Viers BR. Technical Considerations of Single Port Ureteroneocystostomy Utilizing da Vinci SP Platform. Urology. 2019 Jul; 129:236 Epub 2019 Mar 30
    View PubMed
  42. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes. Eur Urol Oncol. 2019 Jul; 2 (4):390-396 Epub 2018 Sept 28
    View PubMed
  43. Boeri L, Soligo M, Frank I, Boorjian SA, Thompson RH, Tollefson M, Quevedo FJ, Cheville JC, Karnes RJ. Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre experience. BJU Int. 2019 Jun; 123 (6):1011-1019 Epub 2019 Jan 08
    View PubMed
  44. Lyon TD, Frank I, Takahashi N, Boorjian SA, Moynagh MR, Shah PH, Tarrell RF, Cheville JC, Viers BR, Tollefson MK. Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2019 Jun; 17 (3):216-222.e5 Epub 2019 Mar 25
    View PubMed
  45. Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, Herrera-Hernandez L, Cheville JC. A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. Hum Pathol. 2019 Jun; 88:48-59 Epub 2019 Apr 01
    View PubMed
  46. Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy. Int Braz J Urol. 2019 May-Jun; 45 (3):468-477
    View PubMed
  47. Lyon TD, Boorjian SA, Shah PH, Tarrell R, Cheville JC, Frank I, Karnes RJ, Thompson RH, Tollefson MK. Comprehensive characterization of perioperative reoperation following radical cystectomy. Urol Oncol. 2019 Apr; 37 (4):292.e11-292.e17 Epub 2019 Jan 22
    View PubMed
  48. Mitra AP, Fairey AS, Skinner EC, Boorjian SA, Frank I, Schoenberg MP, Bivalacqua TJ, Hyndman ME, Reese AC, Steinberg GD, Large MC, Hulsbergen-van de Kaa CA, Bruins HM, Daneshmand S. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation. Urol Oncol. 2019 Jan; 37 (1):48-56 Epub 2018 Nov 13
    View PubMed
  49. Lyon TD, Frank I, Shah PH, Tarrell R, Cheville JC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. The Association of Aspirin Use with Survival Following Radical Cystectomy. J Urol. 2018 Nov; 200 (5):1014-1021 Epub 2018 May 30
    View PubMed
  50. Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer. Scand J Urol. 2018 Oct - Dec; 52 (5-6):340-348 Epub 2019 Jan 02
    View PubMed
  51. Bhindi B, Thompson RH, Lohse CM, Mason RJ, Frank I, Costello BA, Potretzke AM, Hartman RP, Potretzke TA, Boorjian SA, Cheville JC, Leibovich BC. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment. Eur Urol. 2018 Oct; 74 (4):489-497 Epub 2018 July 13
    View PubMed
  52. Agarwal DK, Miest TS, Granberg CF, Frank I, Gargollo PC. Pediatric Robotic Prostatectomy and Pelvic Lymphadenectomy for Embryonal Rhabdomyosarcoma. Urology. 2018 Sep; 119:143-145 Epub 2018 Apr 24
    View PubMed
  53. Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocr Pathol. 2018 Sep; 29 (3):236-241
    View PubMed
  54. Lyon TD, Tollefson MK, Shah PH, Bews K, Frank I, Karnes RJ, Thompson RH, Habermann EB, Boorjian SA. Temporal trends in venous thromboembolism after radical cystectomy. Urol Oncol. 2018 Aug; 36 (8):361.e15-361.e21 Epub 2018 June 07
    View PubMed
  55. Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK. Examining the association between adiposity and biochemical recurrence after radical prostatectomy. Can Urol Assoc J. 2018 Jul; 12 (7):E331-E337 Epub 2018 Mar 19
    View PubMed
  56. Mason RJ, Boorjian SA, Bhindi B, Rangel L, Frank I, Karnes RJ, Tollefson MK. The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy. Clin Genitourin Cancer. 2018 Jun; 16 (3):e629-e636 Epub 2017 Dec 06
    View PubMed
  57. Bailey GC, Frank I, Tollefson MK, Gettman MT, Knoedler JJ. Perioperative outcomes of robot-assisted laparoscopic partial cystectomy. J Robot Surg. 2018 Jun; 12 (2):223-228 Epub 2017 June 10
    View PubMed
  58. Zattoni F, Morlacco A, Nehra A, Frank I, Boorjian SA, Thapa P, Karnes RJ. Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse. Int Braz J Urol. 2018 May-Jun; 44 (3):491-499
    View PubMed
  59. Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. Eur Urol. 2018 May; 73 (5):772-780 Epub 2018 Feb 03
    View PubMed
  60. Linder BJ, Frank I, Occhino JA. Extravesical robotic ureteral reimplantation for ureterovaginal fistula. Int Urogynecol J. 2018 Apr; 29 (4):595-597 Epub 2017 Sept 07
    View PubMed
  61. Moschini M, Morlacco A, Briganti A, Hu B, Colombo R, Montorsi F, Frank I, Daneshmand S, Karnes RJ. Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy. Eur Urol Focus. 2018 Mar; 4 (2):245-251 Epub 2016 Nov 23
    View PubMed
  62. Agarwal DK, Viers BR, Rivera ME, Nienow DA, Frank I, Tollefson MK, Gettman MT. Physical activity monitors can be successfully implemented to assess perioperative activity in urologic surgery. Mhealth. 2018; 4:43 Epub 2018 Sept 26
    View PubMed
  63. Wilhite TJ, Routman D, Arnett AL, Glasgow AE, Habermann EB, Pisansky TM, Boorjian SA, Jethwa KR, Mynderse LA, Roberts KW, Frank I, Choo R, Davis BJ, Stish BJ. Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysis. Bladder (San Franc). 2018; 5 (3):e34 Epub 2018 Aug 23
    View PubMed
  64. Mason RJ, Frank I, Bhindi B, Tollefson MK, Thompson RH, Karnes RJ, Tarrell R, Thapa P, Boorjian SA. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes. World J Urol. 2017 Dec; 35 (12):1879-1884 Epub 2017 Sept 14
    View PubMed
  65. Bhindi B, Karnes RJ, Rangel LJ, Mason RJ, Gettman MT, Frank I, Tollefson MK, Lin DW, Thompson RH, Boorjian SA. Independent Validation of the American Joint Committee on Cancer 8th Edition Prostate Cancer Staging Classification. J Urol. 2017 Dec; 198 (6):1286-1294 Epub 2017 June 29
    View PubMed
  66. Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Tollefson MK, Frank I. Oncologic surveillance following radical cystectomy: an individualized risk-based approach. World J Urol. 2017 Dec; 35 (12):1863-1869 Epub 2017 July 06
    View PubMed
  67. Bhindi B, Carlson RE, Mason RJ, Schulte PJ, Gettman MT, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Leibovich BC, Karnes RJ. Long-term Follow-up of a Matched Cohort Study Evaluating the Role of Adjuvant Radiotherapy for Organ-confined Prostate Cancer With a Positive Surgical Margin. Urology. 2017 Nov; 109:145-152 Epub 2017 Aug 18
    View PubMed
  68. Bhindi B, Frank I, Mason RJ, Tarrell RF, Thapa P, Cheville JC, Costello BA, Pagliaro LC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017 Nov; 72 (5):660-664 Epub 2017 May 22
    View PubMed
  69. Parker WP, Smelser W, Lee EK, Habermann EB, Thapa P, Zaid HB, Frank I, Griebling TL, Tollefson MK, Thompson RH, Holzbeierlein JM, Karnes RJ, Boorjian SA. Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients. Clin Genitourin Cancer. 2017 Aug 1 Epub 2017 Aug 01
    View PubMed
  70. Parker WP, Habermann EB, Day CN, Zaid HB, Frank I, Thompson RH, Tollefson MK, Boorjian SA, Pagliaro LC, Karnes RJ. Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy. Clin Genitourin Cancer. 2017 Jul 22 Epub 2017 July 22
    View PubMed
  71. Bhindi B, Rangel LJ, Mason RJ, Gettman MT, Frank I, Kwon ED, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration. J Urol. 2017 Jul; 198 (1):86-91 Epub 2017 Jan 24
    View PubMed
  72. Cockerill PA, Cheville JC, Boorjian SA, Blackburne A, Thapa P, Tarrell RF, Frank I. Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control. Urology. 2017 Apr; 102:143-147 Epub 2016 Nov 16
    View PubMed
  73. Parker WP, Cheville JC, Frank I, Zaid HB, Lohse CM, Boorjian SA, Leibovich BC, Thompson RH. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. Eur Urol. 2017 Apr; 71 (4):665-673 Epub 2016 June 07
    View PubMed
  74. Muppa P, Gupta S, Frank I, Boorjian SA, Karnes RJ, Thompson RH, Thapa P, Tarrell RF, Herrera Hernandez LP, Jimenez RE, Cheville JC. Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy. Pathology. 2017 Apr; 49(3):259-266. Epub 2017 Mar 01.
    View PubMed
  75. Parker WP, Tollefson MK, Heins CN, Hanson KT, Hanson KT, Habermann EB, Zaid HB, Frank I, Thompson RH, Boorjian SA. Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program. Urol Oncol. 2016 Dec; 34 (12):532.e13-532.e19 Epub 2016 Aug 05
    View PubMed
  76. Parker WP, Ho PL, Boorjian SA, Melquist JJ, Thapa P, Holzbeierlein JM, Frank I, Kamat AM, Lee EK. The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy. World J Urol. 2016 Nov; 34 (11):1561-1566 Epub 2016 Mar 04
    View PubMed
  77. Westerman ME, Parker WP, Viers BR, Rivera ME, Karnes RJ, Frank I, Tarrell R, Thapa P, Thompson RH, Tollefson MK, Boorjian SA. Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes. Urol Oncol. 2016 Nov; 34(11):485.e1-485.e6. Epub 2016 Jul 14.
    View PubMed
  78. Zaid HB, Yang DY, Tollefson MK, Frank I, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Safety and Efficacy of Extended Duration of Thromboembolic Prophylaxis Following Radical Cystectomy: An Initial Institutional Experience. Urol Pract. 2016 Nov; 3 (6):462-467 Epub 2016 Aug 18
    View PubMed
  79. Moreira DM, Gershman B, Rangel LJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Gettman MT, Karnes RJ. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU Int. 2016 Sep; 118: (3)379-83.
    View PubMed
  80. Parker WP, Toussi A, Tollefson MK, Frank I, Thompson RH, Zaid HB, Thapa P, Boorjian SA. Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy. Urology. 2016 Aug; 94:96-101. Epub 2016 Apr 25.
    View PubMed
  81. Zaid HB, Yang DY, Tollefson MK, Frank I, Winters JL, Thapa P, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy. Urology. 2016 Jun; 92:57-62. Epub 2016 Mar 08.
    View PubMed
  82. Toussi A, Stewart-Merrill SB, Boorjian SA, Psutka SP, Thompson RH, Frank I, Tollefson MK, Gettman MT, Carlson RE, Rangel LJ, Karnes RJ. Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy-What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression? J Urol. 2016 Jun; 195(6):1754-9. Epub 2015 Dec 23.
    View PubMed
  83. Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ. Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup. J Urol. 2016 Jun; 195 (6):1773-8 Epub 2015 Dec 23
    View PubMed
  84. Gershman B, Psutka SP, McGovern FJ, Dahl DM, Tabatabaei S, Gettman MT, Frank I, Carlson RE, Rangel LJ, Barry MJ, Blute ML, Karnes RJ. Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals. Eur Urol Focus. 2016 Jun; 2 (2):172-179 Epub 2015 July 15
    View PubMed
  85. Stewart-Merrill SB, Alahdab F, Benkhadra K, Wang Z, Sorita A, Boorjian SA, Frank I, Murad MH. Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis. Urol Oncol. 2016 May; 34 (5):236.e13-21 Epub 2016 Feb 09
    View PubMed
  86. Weingarten TN, Taccolini AM, Ahle ST, Dietz KR, Dowd SS, Frank I, Boorjian SA, Thapa P, Hanson AC, Schroeder DR, Sprung J. Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study. Can J Anaesth. 2016 May; 63(5):584-95. Epub 2016 Feb 05.
    View PubMed
  87. Cockerill PA, Knoedler JJ, Frank I, Tarrell R, Karnes RJ. Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer. BJU Int. 2016 Mar; 117 (3):456-62 Epub 2015 May 23
    View PubMed
  88. Kaushik D, Boorjian SA, Thompson RH, Eisenberg MS, Carlson RE, Bergstralh EJ, Frank I, Gettman MT, Tollefson MK, Karnes RJ. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. Int Braz J Urol. 2016 Nov-Dec; 42(6):1091-1098.
    View PubMed
  89. Zaid HB, Yang DY, Tollefson MK, Frank I, Parker WP, Thompson RH, Karnes RJ, Boorjian SA. Safety and efficacy of extended duration of thromboembolic prophylaxis following radical cystectomy: an initial institutional experience Urology Practice. 2016; 3(6):462-7. Epub 1900 Jan 01.
  90. Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Urol Oncol. 2016 Jan; 34 (1):4.e1-9 Epub 2015 Aug 29
    View PubMed
  91. Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka SP, Lohse CM, Cheville JC, Leibovich BC, Frank I. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach. J Clin Oncol. 2015 Dec 10; 33 (35):4151-7 Epub 2015 Sept 08
    View PubMed
  92. Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 2015 Oct; 47 (6):533-42
    View PubMed
  93. Viers BR, Lightner DJ, Rivera ME, Tollefson MK, Boorjian SA, Karnes RJ, Thompson RH, O'Neil DA, Hamilton RL, Gardner MR, Bundrick M, Jenkins SM, Pruthi S, Frank I, Gettman MT. Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial. Eur Urol. 2015 Oct; 68 (4):729-35 Epub 2015 Apr 18
    View PubMed
  94. Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson MK, Frank I. Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach. Urol Oncol. 2015 Aug; 33(8):339.e1-8. Epub 2015 May 29.
    View PubMed
  95. Gershman B, Eisenberg MS, Thompson RH, Frank I, Kaushik D, Tarrell R, Thapa P, Boorjian SA. Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. Int J Urol. 2015 Jul; 22(7):651-6. Epub 2015 Apr 16.
    View PubMed
  96. Kaushik D, Frank I, Boorjian SA, Cheville JC, Eisenberg MS, Thapa P, Tarrell RF, Thompson RH. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. Int J Urol. 2015 Jun; 22(6):549-54. Epub 2015 Mar 11.
    View PubMed
  97. Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Frank I, Carrasco A, Stewart SB, Tarrell R, Thapa P, Tollefson MK. Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting. J Urol. 2015 May; 193 (5):1507-13 Epub 2014 Nov 22
    View PubMed
  98. Knoedler J, Frank I. Organ-sparing surgery in urology: partial cystectomy. Curr Opin Urol. 2015 Mar; 25(2):111-5.
    View PubMed
  99. Clifton MM, Psutka SP, Boorjian SA, Cheville JC, Thapa P, Thompson RH, Tollefson MK, Karnes RJ, Frank I. Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy. World J Urol. 2015 Mar; 33 (3):373-9 Epub 2014 May 15
    View PubMed
  100. Abel EJ, Linder BJ, Bauman TM, Bauer RM, Thompson RH, Thapa P, Devon ON, Tarrell RF, Frank I, Jarrard DF, Downs TM, Boorjian SA. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur Urol. 2014 Dec; 66 (6):1139-47 Epub 2014 Sept 04
    View PubMed
  101. Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SP, Bergstralh EJ, Rangel L, Karnes RJ. Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy. Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):332-7. Epub 2014 Aug 26.
    View PubMed
  102. Viers BR, Sukov WR, Gettman MT, Rangel LJ, Bergstralh EJ, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy. Eur Urol. 2014 Dec; 66: (6)1116-24.
    View PubMed
  103. Yelfimov DA, Frank I, Boorjian SA, Thapa P, Cheville JC, Tollefson MK. Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer. World J Urol. 2014 Dec; 32 (6):1463-8 Epub 2014 Jan 14
    View PubMed
  104. Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014 Dec; 66 (6):1157-64 Epub 2014 Feb 26
    View PubMed
  105. Knoedler JJ, Boorjian SA, Tollefson MK, Cheville JC, Thapa P, Tarrell RF, Frank I. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy. BJU Int. 2014 Dec; 114(6):832-6.
    View PubMed
  106. Kaushik D, Frank I, Eisenberg MS, Cheville JC, Tarrell R, Thapa P, Thompson RH, Boorjian SA. Gender-specific survival following radical cystectomy for pT4 bladder cancer. World J Urol. 2014 Dec; 32 (6):1433-9 Epub 2013 Dec 21
    View PubMed
  107. Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, Stewart SB, Thapa P, Tarrell RF, Cheville JC, Tollefson MK. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer. 2014 Sep 15; 120 (18):2910-8 Epub 2014 May 19
    View PubMed
  108. Scavonetto F, Yeoh TY, Umbreit EC, Weingarten TN, Gettman MT, Frank I, Boorjian SA, Karnes RJ, Schroeder DR, Rangel LJ, Hanson AC, Hofer RE, Sessler DI, Sprung J. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. Br J Anaesth. 2014 Jul; 113 Suppl 1:i95-102 Epub 2013 Dec 16
    View PubMed
  109. Breau RH, Karnes RJ, Farmer SA, Thapa P, Cagiannos I, Morash C, Frank I. Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis. BJU Int. 2014 Jun; 113(6):900-6. Epub 2013 Nov 27.
    View PubMed
  110. Rivera ME, Frank I, Viers BR, Rangel LJ, Krambeck AE. Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis. J Endourol. 2014 Jun; 28 (6):699-703 Epub 2014 Feb 25
    View PubMed
  111. Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Thompson RH, Han LC, Shah ND, Smaldone MC, Gross CP, Frank I, Weight CJ, Beebe TJ, Tilburt JC. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU Int. 2014 May; 113: (5b)E106-11.
    View PubMed
  112. Schneider SA, Sukov WR, Frank I, Boorjian SA, Costello BA, Tarrell RF, Thapa P, Houston Thompson R, Tollefson MK, Jeffrey Karnes R, Cheville JC. Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. Mod Pathol. 2014 May; 27 (5):758-64 Epub 2013 Nov 01
    View PubMed
  113. Linder BJ, Boorjian SA, Hudolin T, Cheville JC, Thapa P, Tarrell RF, Frank I. Late recurrence after radical cystectomy: patterns, risk factors and outcomes. J Urol. 2014 May; 191(5):1256-61. Epub 2013 Dec 10.
    View PubMed
  114. Thompson RH, Boorjian SA, Kim SP, Cheville JC, Thapa P, Tarrel R, Dronca R, Costello B, Frank I. Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients. BJU Int. 2014 May; 113(5b):E17-21. Epub 2013 Sep 05.
    View PubMed
  115. Eisenberg MS, Thompson RH, Frank I, Kim SP, Cotter KJ, Tollefson MK, Kaushik D, Thapa P, Tarrell R, Boorjian SA. Long-term renal function outcomes after radical cystectomy. J Urol. 2014 Mar; 191 (3):619-25 Epub 2013 Sept 12
    View PubMed
  116. Wang JK, Boorjian SA, Frank I, Tarrell RF, Thapa P, Jacob EK, Tauscher CD, Tollefson MK. Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy. Urology. 2014 Jan; 83(1):140-5. Epub 2013 Oct 16.
    View PubMed
  117. Hubanks JM, Boorjian SA, Frank I, Gettman MT, Thompson RH, Rangel LJ, Bergstralh EJ, Karnes RJ. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. UROL. ONCOL. 2014; 32(1):26.e1-7.
  118. Mikel Hubanks J, Boorjian SA, Frank I, Gettman MT, Houston Thompson R, Rangel LJ, Bergstralh EJ, Jeffrey Karnes R. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes. Urol Oncol. 2014 Jan; 32 (1):26.e1-7 Epub 2013 Feb 06
    View PubMed
  119. Eisenberg MS, Boorjian SA, Cheville JC, Thompson RH, Thapa P, Kaushik D, Frank I. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. J Urol. 2013 Dec; 190 (6):2005-10 Epub 2013 June 14
    View PubMed
  120. Linder BJ, Boorjian SA, Cheville JC, Sukov WR, Thapa P, Tarrell RF, Frank I. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer? J Urol. 2013 Nov; 190(5):1692-6. Epub 2013 May 23.
    View PubMed
  121. Woodrum DA, Kawashima A, Karnes RJ, Davis BJ, Frank I, Engen DE, Gorny KR, Felmlee JP, Callstrom MR, Mynderse LA. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience. Urology. 2013 Oct; 82 (4):870-5 Epub 2013 Aug 01
    View PubMed
  122. Kim SP, Tilburt JC, Karnes RJ, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB, Trinh QD, Sun M, O'Malley RL, Nguyen PL. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology. 2013 Oct; 82: (4)807-12.
    View PubMed
  123. Linder BJ, Frank I, Umbreit EC, Shimko MS, Fernandez N, Rangel LJ, Karnes RJ. Standard and saturation transrectal prostate biopsy techniques are equally accurate among prostate cancer active surveillance candidates. Int J Urol 2013 Sep; 20 (9):860-4 Epub 2012 Dec 20
    View PubMed
  124. Kim SP, Shah ND, Weight CJ, Thompson RH, Wang JK, Karnes RJ, Han LC, Ziegenfuss JY, Frank I, Tollefson MK, Boorjian SA. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer. BJU Int. 2013 Aug; 112 (4):478-84 Epub 2013 Mar 01
    View PubMed
  125. Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer. J Urol. 2013 Jul; 190 (1):55-60 Epub 2013 Jan 09
    View PubMed
  126. Kim SP, Shah ND, Karnes RJ, Weight CJ, Shippee ND, Han LC, Boorjian SA, Smaldone MC, Frank I, Gettman MT, Tollefson MK, Thompson RH. Hospitalization costs for radical prostatectomy attributable to robotic surgery. Eur Urol. 2013 Jul; 64(1):11-6. Epub 2012 Aug 20.
    View PubMed
  127. Linder BJ, Frank I, Cheville JC, Tollefson MK, Thompson RH, Tarrell RF, Thapa P, Boorjian SA. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol. 2013 May; 63 (5):839-45 Epub 2013 Jan 11
    View PubMed
  128. Linder BJ, Frank I, Cheville JC, Thompson RH, Thapa P, Tarrell RF, Boorjian SA. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis. J Urol. 2013 May; 189(5):1670-5. Epub 2012 Nov 06.
    View PubMed
  129. Wang JK, Boorjian SA, Cheville JC, Kim SP, Tarrell RF, Thapa P, Frank I. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis. World J Urol. 2012 Dec; 30(6):801-6. Epub 2012 Nov 07.
    View PubMed
  130. Tollefson MK, Boorjian SA, Farmer SA, Frank I. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease. World J Urol. 2012 Dec; 30 (6):795-9 Epub 2012 Mar 25
    View PubMed
  131. Zarei S, Frank I, Boorjian SA, Thompson RH, Kim S, Weight C, Tarrell R, Thapa P, Cheville JC. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications. J Urol. 2012 Nov; 188(5):1706-11. Epub 2012 Sep 19.
    View PubMed
  132. Kim SP, Boorjian SA, Shah ND, Karnes RJ, Weight CJ, Moriarty JP, Tollefson MK, Shippee ND, Frank I. Contemporary trends of in-hospital complications and mortality for radical cystectomy. BJU Int. 2012 Oct; 110 (8):1163-8 Epub 2012 Mar 22
    View PubMed
  133. Knoedler JJ, Boorjian SA, Kim SP, Weight CJ, Thapa P, Tarrell RF, Cheville JC, Frank I. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J Urol. 2012 Oct; 188(4):1115-9. Epub 2012 Aug 15.
    View PubMed
  134. Kim SP, Frank I, Cheville JC, Thompson RH, Weight CJ, Thapa P, Boorjian SA. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol. 2012 Aug; 188 (2):405-9 Epub 2012 June 14
    View PubMed
  135. Kim SP, Shah ND, Karnes RJ, Weight CJ, Frank I, Moriarty JP, Han LC, Borah B, Tollefson MK, Boorjian SA. The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. J Urol. 2012 Jun; 187 (6):2011-7 Epub 2012 Apr 11
    View PubMed
  136. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012 Feb; 79 (2):356-60
    View PubMed
  137. Boorjian SA, Kim SP, Weight CJ, Cheville JC, Thapa P, Frank I. Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol. 2011 Dec; 60 (6):1266-72 Epub 2011 Aug 22
    View PubMed
  138. Inman BA, Frank I, Boorjian SA, Akornor JW, Karnes RJ, Leibovich BC, Blute ML, Bergstralh EJ. Dynamic prediction of metastases after radical prostatectomy for prostate cancer. BJU Int. 2011 Dec; 108: (11)1762-8.
    View PubMed
  139. Boorjian SA, Tollefson MK, Cheville JC, Costello BA, Thapa P, Frank I. Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. J Urol. 2011 Nov; 186 (5):1796-802 Epub 2011 Sept 25
    View PubMed
  140. Tollefson MK, Frank I, Gettman MT. Robotic-assisted radical prostatectomy decreases the incidence and morbidity of surgical site infections. Urology. 2011 Oct; 78(4):827-31. Epub 2011 Jul 29.
    View PubMed
  141. Tollefson MK, Gettman MT, Karnes RJ, Frank I. Administrative data sets are inaccurate for assessing functional outcomes after radical prostatectomy. J Urol. 2011 May; 185 (5):1686-90 Epub 2011 Mar 21
    View PubMed
  142. Siddiqui SA, Boorjian SA, Blute ML, Rangel LJ, Bergstralh EJ, Karnes RJ, Frank I. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer. BJU Int. 2011 Feb; 107(3):383-8.
    View PubMed
  143. Shimko MS, Tollefson MK, Umbreit EC, Farmer SA, Blute ML, Frank I. Long-term complications of conduit urinary diversion. J Urol. 2011 Feb; 185 (2):562-7 Epub 2010 Dec 18
    View PubMed
  144. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Blute ML, Campbell SC. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010 Sep; 58 (3):340-5 Epub 2010 June 09
    View PubMed
  145. Tollefson MK, Blute ML, Rangel LJ, Karnes RJ, Frank I. Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy. J Urol. 2010 Sep; 184(3):925-9.
    View PubMed
  146. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, Gill IS, Campbell SC, Blute ML. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 2010 Sep; 58 (3):331-6 Epub 2010 June 09
    View PubMed
  147. Tollefson M, Magera J, Sebo T, Cohen J, Drauch A, Maier J, Frank I. Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology? BJU Int. 2010 Aug; 106(4):484-8. Epub 2010 Mar 01.
    View PubMed
  148. Umbreit EC, Crispen PL, Shimko MS, Farmer SA, Blute ML, Frank I. Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma. Cancer. 2010 Jul 15; 116(14):3399-407.
    View PubMed
  149. Weisbrod AJ, Atwell TD, Frank I, Callstrom MR, Farrell MA, Mandrekar JN, Charboneau JW. Percutaneous cryoablation of masses in a solitary kidney. AJR Am J Roentgenol. 2010 Jun; 194: (6)1620-5.
    View PubMed
  150. Tollefson MK, Elliott DS, Zincke H, Frank I. Long-term outcome of ureterosigmoidostomy: an analysis of patients with >10 years of follow-up. BJU Int. 2010 Mar; 105(6):860-3. Epub 2009 Aug 13.
    View PubMed
  151. Tollefson MK, Blute ML, Farmer SA, Frank I. Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. J Urol. 2010 Jan; 183 (1):81-6
    View PubMed
  152. Siddiqui SA, Frank I, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol. BJU Int. 2009 Sep; 104 (6):778-85 Epub 2009 Mar 11
    View PubMed
  153. Granberg CF, Frank I, Gettman MT. Transvesical NOTES: Current experience and potential implications for urologic applications. J Endourol. 2009 May; 23: (5)747-52.
    View PubMed
  154. Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer. 2009 Mar; 16 (1):123-37 Epub 2008 Oct 09
    View PubMed
  155. Granberg CF, Boorjian SA, Crispen PL, Tollefson MK, Farmer SA, Frank I, Blute ML. Functional and oncological outcomes after orthotopic neobladder reconstruction in women. BJU Int. 2008 Dec; 102 (11):1551-5 Epub 2008 Oct 08
    View PubMed
  156. Box G, Averch T, Cadeddu J, Cherullo E, Clayman R, Desai M, Frank I, Gettman M, Gill I, Gupta M, Haber GP, Kaouk J, Landman J, Lima E, Ponsky L, Rane A, Sawyer M, Humphreys M, Urologic NOTES Working Group. Nomenclature of natural orifice translumenal endoscopic surgery (NOTES) and laparoendoscopic single-site surgery (LESS) procedures in urology. J Endourol. 2008 Nov; 22(11):2575-81.
    View PubMed
  157. Rogers CG, Menon M, Weise ES, Gettman MT, Frank I, Shephard DL, Abrahams HM, Green JM, Savatta DJ, Bhayani SB. Robotic partial nephrectomy: a multi-institutional analysis. J Robot Surg. 2008 Sep; 2 (3):141-3 Epub 2008 July 26
    View PubMed
  158. Magera JS Jr, Adam Childs M, Frank I. Robot-assisted laparoscopic transvesical diverticulectomy and simple prostatectomy. J Robot Surg. 2008 Sep; 2 (3):205-8 Epub 2008 July 26
    View PubMed
  159. Routh JC, Bacon DR, Leibovich BC, Zincke H, Blute ML, Frank I. How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery. BJU Int. 2008 Aug; 102 (3):301-4 Epub 2008 Apr 11
    View PubMed
  160. Boorjian SA, Sheinin Y, Crispen PL, Farmer SA, Lohse CM, Kuntz SM, Leibovich BC, Kwon ED, Frank I. T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res. 2008 Aug 1; 14 (15):4800-8
    View PubMed
  161. Boorjian SA, Crispen PL, Carlson RE, Rangel LJ, Karnes RJ, Frank I, Gettman MT. Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy. J Endourol. 2008 Jul; 22(7):1471-6.
    View PubMed
  162. Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int. 2008 Jun; 101(11):1375-9.
    View PubMed
  163. Ponsky L, Cherullo E, Moinzadeh A, Desai M, Kaouk J, Haber GP, Chen D, Ng C, Fuchs G, Singh D, Finelli A, Frank I, Matin S. The Hem-o-lok clip is safe for laparoscopic nephrectomy: a multi-institutional review. Urology. 2008 Apr; 71(4):593-6. Epub 2008 Mar 04.
    View PubMed
  164. Magera JS Jr, Frank I, Lohse CM, Leibovich BC, Cheville JC, Blute ML. Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol. 2008 Mar; 179 (3):853-6 Epub 2008 Jan 25
    View PubMed
  165. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers. BJU Int. 2008 Feb; 101(3):299-304. Epub 2007 Oct 08.
    View PubMed
  166. Elliott DS, Frank I, Chow GK. Robotics and laparoscopy for vaginal prolapse and incontinence. Current Bladder Dysfunction Reports. 2007 Dec; 2(4):214-8.
  167. Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC, Blute ML. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology. 2007 Dec; 70 (6):1064-8
    View PubMed
  168. Granberg CF, Krambeck AE, Leibovich BC, Frank I, Lohse CM, Gettman MT, Blute ML, Chow GC. Potential underdetection of pT(3a) renal-cell carcinoma with laparoscopic morcellation. J Endourol. 2007 Oct; 21 (10):1183-6
    View PubMed
  169. Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. J Urol. 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. Epub 2007 Jul 16.
    View PubMed
  170. Blute ML, Boorjian SA, Leibovich BC, Lohse CM, Frank I, Karnes RJ. Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol. 2007 Aug; 178 (2):440-5; discussion 444 Epub 2007 June 11
    View PubMed
  171. Thompson RH, Blute ML, Krambeck AE, Lohse CM, Magera JS, Leibovich BC, Kwon ED, Frank I, Cheville JC. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol. 2007 Jul; 31 (7):1089-93
    View PubMed
  172. Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007 Jul; 178(1):41-6. Epub 2007 May 11.
    View PubMed
  173. Atwell TD, Farrell MA, Callstrom MR, Charboneau JW, Leibovich BC, Frank I, Patterson DE. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol. 2007 May; 188: (5)1195-200.
    View PubMed
  174. Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007 Apr 15; 109 (8):1499-505
    View PubMed
  175. Thompson RH, Frank I, Lohse CM, Saad IR, Fergany A, Zincke H, Leibovich BC, Blute ML, Novick AC. The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol. 2007 Feb; 177 (2):471-6
    View PubMed
  176. Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, Frank I. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. J Urol. 2007 Feb; 177 (2):477-80
    View PubMed
  177. Iwaszko MR, Blute ML, Frank I, Leibovich BC, Cheville JC. Long-term Outcome of Multiple Ipsilateral Renal Tumors Found at Time of Planned Nephron Sparing Surgery. BJU. 2007.
  178. Siddiqui SA, Frank I, Leibovich BC, Cheville JC, Lohse CM, Zincke H, Blute ML. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. J Urol. 2007 Jan; 177 (1):59-62
    View PubMed
  179. Frank I, Blute ML. Renal cell carcinoma: classification and advances in staging. Contemp Urol. 2006 Aug; 18(8):42-7.
  180. Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival. Cancer. 2006 Jul 1; 107 (1):46-53
    View PubMed
  181. Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006 Apr 1; 66 (7):3381-5
    View PubMed
  182. Frank I. Colombo JR Jr. Rubinstein M Desai M Kaouk J Gill ISLaparoscopic partial nephrectomy for centrally located renal tumorsJournal of Urology. 2006 Mar; 175(3 Pt 1):849-52.
  183. Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer. 2006 Jan 15; 106 (2):304-12
    View PubMed
  184. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Frank I, Kwon ED, Merchan JR, Blute ML. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol. 2005 Nov; 174 (5):1759-63; discussion 1763
    View PubMed
  185. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 2005 Oct; 174 (4 Pt 1):1218-21
    View PubMed
  186. Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC, Kwon ED. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005 Aug 1; 104 (3):511-20
    View PubMed
  187. Thompson RH, Cheville JC, Lohse CM, Webster WS, Zincke H, Kwon ED, Frank I, Blute ML, Leibovich BC. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer. 2005 Jul 1; 104 (1):53-60
    View PubMed
  188. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol. 2005 Jun; 173 (6):1889-92
    View PubMed
  189. Krambeck AE, Farrell MA, Charboneau JW, Frank I, Zincke H. Intraperitoneal drop metastasis after radiofrequency ablation of pararenal tumor recurrences. Urology. 2005 Apr; 65(4):E13-5.
  190. Krambeck AE, Farrell MA, Charboneau JW, Frank I, Zincke H. Intraperitoneal drop metastasis after radiofrequency ablation of pararenal tumor recurrences. Urology. 2005 Apr; 65: (4)797.
    View PubMed
  191. Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Frank I, Kwon ED, Zincke H, Blute ML. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? J Urol. 2005 Mar; 173 (3):918-21
    View PubMed
  192. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol. 2005 Mar; 173 (3):716-9
    View PubMed
  193. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Kwon ED, Zincke H. pT2 classification for renal cell carcinoma. Can its accuracy be improved? J Urol. 2005 Feb; 173 (2):380-4
    View PubMed
  194. Gill IS, Colombo JR Jr, Frank I, Moinzadeh A, Kaouk J, Desai M. Laparoscopic partial nephrectomy for hilar tumors. Journal of Urology ,. 2005; 174: (3)850.
  195. Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement. Cancer. 2004 Oct 15; 101 (8):1803-8
    View PubMed
  196. Elliott DS, Frank I, DiMarco DS, Chow GK. Gynecologic use of robotically assisted laparoscopy: sacrocolpopexy for the treatment of high-grade vaginal vault prolapse. Am J Surg. 2004 Oct; 188(4A Suppl S):52S-56S.
    View PubMed
  197. Frank I, Zincke H. Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer. Changes of follow-up protocol. Urologe A. 2004 Sep; 43 Suppl 3:S125-8
    View PubMed
  198. Wehle MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology. 2004 Jul; 64 (1):49-52
    View PubMed
  199. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, Blute ML. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004 Apr; 28 (4):435-41
    View PubMed
  200. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Leibovich BC, Zincke H. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol. 2003 Dec; 170 (6 Pt 1):2225-32
    View PubMed
  201. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003 Dec; 170 (6 Pt 1):2217-20
    View PubMed
  202. Frank I, Cheville JC, Blute ML, Lohse CM, Nehra A, Weaver AL, Karnes RJ, Zincke H. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer. 2003 May 15; 97 (10):2425-31
    View PubMed
  203. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003 Apr 1; 97 (7):1663-71
    View PubMed
  204. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol. 2002 Dec; 168 (6):2395-400
    View PubMed
  205. Frank I, Parra RO. Radical Perineal Prostatectomy: An Update. AUA Update Series (3),. 2002; XXI:
  206. Frank I, Petrou SP, Parra RO. Radical perineal prostatectomy: a lost art? Journal of Pelvic Surgery. 2001 Jul/Aug; 7(4):214-21.
  207. Petrou SP, Frank I. Complications and initial continence rates after a repeat pubovaginal sling procedure for recurrent stress urinary incontinence. J Urol. 2001 Jun; 165 (6 Pt 1):1979-81
    View PubMed
  208. Frank I, Elliott DS, Barrett DM. Success of de novo reimplantation of the artificial genitourinary sphincter. J Urol. 2000 Jun; 163(6):1702-3.
    View PubMed
  209. Frank I, Parra RO. Radical perineal prostatectomy: a contemporary review of indications, surgical technique, and outcome. Bulletin of Urology Sociedade Brasileira de Urologia,. 2000;
  210. Frank I, Lieber MM. Gas containing cavernous abscess secondary to an intra-abdominal abscess. J Urol. 1999 Oct; 162(4):1382-3.
    View PubMed